Skip to content

Prevalence of Abnormal Pap Smear

Prevalence of Abnormal Pap Smear in Sohag University Hospital Outpatient Clinic

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06641531
Enrollment
300
Registered
2024-10-15
Start date
2024-10-01
Completion date
2025-04-01
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervix Cancer

Brief summary

This study aims to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.

Detailed description

This study aims to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending Sohag university hospital outpatient clinic. Participating women will be subjected to accurate history taking regarding age, parity, Body mass index, contraceptive use, menstrual history, and duration of marital life, frequency of previous marriages if any, and the status of cervix by per-vaginal examination of the patients. The patient put in dorsal lithotomy position and place the feet in stirrups or on foot rests . then, the physician will insert a cusco speculum into the vagina to hold vaginal wall open . The specimens will be collected as follows; firstly, the speculum will be inserted without lubricant. Any mucous, discharge or blood will be removed with dry cotton. A wooden spatula will be used for sampling ectocervix which will be rotated 360 degrees. For sampling endocervix, A brush or a swab will be rotated only 90 degrees as the circumferential bristles will be in contact with the entire surface the moment the brush is inserted. The samples will be applied to the slides which will be encoded and immediately fixed in 95% ethanol and the samples will be transferred to pathology department to be stained by the standard Papanicolaou stain . The Bethesda System will be used for cytological interpretation.

Interventions

OTHERScreening pap smear test

The patient put in dorsal lithotomy position and place the feet in stirrups or on foot rests . then, the physician will insert a cusco speculum into the vagina to hold vaginal wall open . The specimens will be collected as follows; firstly, the speculum will be inserted without lubricant. Any mucous, discharge or blood will be removed with dry cotton. A wooden spatula will be used for sampling ectocervix which will be rotated 360 degrees. For sampling endocervix, A brush or a swab will be rotated only 90 degrees as the circumferential bristles will be in contact with the entire surface the moment the brush is inserted. The samples will be applied to the slides which will be encoded and immediately fixed in 95% ethanol and the samples will be transferred to pathology department to be stained by the standard Papanicolaou stain

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Non pregnant sexually active women aged from 21 to 60 years old. * Patients who didn't have their pap smear done in last 3 years . * Patient who had previous abnormal pap smear and coming for follow up.

Exclusion criteria

* Women who were diagnosed cervical cancer that was treated. * Women who underwent total hysterectomy. * Women who are pregnant. * Patients whose pap smear was done in last 3 years with reassuring results.

Design outcomes

Primary

MeasureTime frameDescription
number of abnormal pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.From October 2024 to April 2025to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.

Countries

Egypt

Contacts

Primary ContactMostafa radwan, Master
mostafa_redwan_post@med.sohag.edu.eg01013774970

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026